Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP992286.RAzQBJ6-iIhKX8mJLFfxwbi1CxRTcN-mC-ER71QdGuzf0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP992286.RAzQBJ6-iIhKX8mJLFfxwbi1CxRTcN-mC-ER71QdGuzf0130_assertion type Assertion NP992286.RAzQBJ6-iIhKX8mJLFfxwbi1CxRTcN-mC-ER71QdGuzf0130_head.
- NP992286.RAzQBJ6-iIhKX8mJLFfxwbi1CxRTcN-mC-ER71QdGuzf0130_assertion description "[We analysed the deregulation at the transcriptional level of the genes encoding Rab proteins and Rab-interacting proteins in bladder cancer pathogenesis, distinguishing between the two main progression pathways so far identified in bladder cancer: the Ta pathway characterized by a high frequency of FGFR3 mutation and the carcinoma in situ pathway where no or infrequent FGFR3 mutations have been identified.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP992286.RAzQBJ6-iIhKX8mJLFfxwbi1CxRTcN-mC-ER71QdGuzf0130_provenance.
- NP992286.RAzQBJ6-iIhKX8mJLFfxwbi1CxRTcN-mC-ER71QdGuzf0130_assertion evidence source_evidence_literature NP992286.RAzQBJ6-iIhKX8mJLFfxwbi1CxRTcN-mC-ER71QdGuzf0130_provenance.
- NP992286.RAzQBJ6-iIhKX8mJLFfxwbi1CxRTcN-mC-ER71QdGuzf0130_assertion SIO_000772 22724020 NP992286.RAzQBJ6-iIhKX8mJLFfxwbi1CxRTcN-mC-ER71QdGuzf0130_provenance.
- NP992286.RAzQBJ6-iIhKX8mJLFfxwbi1CxRTcN-mC-ER71QdGuzf0130_assertion wasDerivedFrom befree-2016 NP992286.RAzQBJ6-iIhKX8mJLFfxwbi1CxRTcN-mC-ER71QdGuzf0130_provenance.
- NP992286.RAzQBJ6-iIhKX8mJLFfxwbi1CxRTcN-mC-ER71QdGuzf0130_assertion wasGeneratedBy ECO_0000203 NP992286.RAzQBJ6-iIhKX8mJLFfxwbi1CxRTcN-mC-ER71QdGuzf0130_provenance.